HONG KONG, /PRNewswire/ — Delos Capital, a Hong Kong-headquartered life sciences venture capital fund with a global presence and investment mandate, announces the successful $300 million first close of its Fund III.
Delos Capital Announces $300 Million First Close of its Third Life Sciences Fund
Comments are closed.